|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.21 USD | -0.83% |
|
+1.01% | -12.24% |
| Capitalization | 1.98TCr 1.7TCr 1.58TCr 1.47TCr 2.71TCr 1,70100Cr 3.02TCr 19TCr 7.24TCr 80TCr 7.44TCr 7.28TCr 2,92200Cr | P/E ratio 2025 * |
12x | P/E ratio 2026 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.17TCr 1.85TCr 1.73TCr 1.61TCr 2.97TCr 1,86000Cr 3.3TCr 21TCr 7.91TCr 87TCr 8.13TCr 7.96TCr 3,19500Cr | EV / Sales 2025 * |
2.22x | EV / Sales 2026 * | 1.89x |
| Free-Float |
85.5% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Biogen Inc.
More recommendations
More press releases
More news
| 1 day | -0.83% | ||
| 1 week | +1.01% | ||
| Current month | +6.86% | ||
| 1 month | -0.94% | ||
| 3 months | +18.37% | ||
| 6 months | -9.82% | ||
| Current year | -12.24% |
| 1 week | 129.08 |  | 137.84 |
| 1 month | 123.21 | | 137.84 |
| Current year | 110.04 | | 157.09 |
| 1 year | 110.04 | | 238 |
| 3 years | 110.04 | | 319.76 |
| 5 years | 110.04 | | 468.55 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 59 | 01/03/2025 |
Jane Grogan
CTO | Chief Tech/Sci/R&D Officer | 58 | 02/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Caroline Dorsa
CHM | Chairman | 65 | 26/06/2023 |
Eric Rowinsky
BRD | Director/Board Member | 68 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 76 | 01/01/2010 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 4.3% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.83% | +1.01% | -42.34% | -38.66% | 1.98TCr | ||
| -0.61% | -0.03% | -19.06% | -16.16% | 7.7TCr | ||
| +1.43% | +3.72% | -47.00% | -8.66% | 5.91TCr | ||
| -2.13% | +5.70% | +30.98% | +29.06% | 5.6TCr | ||
| -0.96% | +4.49% | +17.90% | +98.92% | 3.83TCr | ||
| -2.23% | +10.30% | +62.59% | +724.41% | 1.75TCr | ||
| +0.37% | -4.79% | +123.13% | +118.89% | 1.75TCr | ||
| -0.04% | -.--% | +70.62% | +129.06% | 1.4TCr | ||
| -2.49% | +0.20% | +12.94% | -14.77% | 1.36TCr | ||
| -1.87% | +10.33% | -71.36% | -80.91% | 1.33TCr | ||
| Average | -1.10% | +2.44% | +13.84% | +94.12% | 3.26TCr | |
| Weighted average by Cap. | -0.98% | +2.08% | +2.45% | +55.71% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 978.67Cr 836.86Cr 779.51Cr 725.02Cr 1.34TCr 84TCr 1.49TCr 9.34TCr 3.57TCr 39TCr 3.67TCr 3.59TCr 1,44200Cr | 1.02TCr 871.12Cr 811.42Cr 754.7Cr 1.39TCr 87TCr 1.55TCr 9.72TCr 3.72TCr 41TCr 3.82TCr 3.74TCr 1,50100Cr |
| Net income | 160.71Cr 137.42Cr 128.01Cr 119.06Cr 219.98Cr 14TCr 244.47Cr 1.53TCr 586.43Cr 6.46TCr 602.74Cr 590.32Cr 24TCr | 191.89Cr 164.09Cr 152.84Cr 142.16Cr 262.67Cr 16TCr 291.91Cr 1.83TCr 700.21Cr 7.71TCr 719.69Cr 704.86Cr 28TCr |
| Net Debt | 185.22Cr 158.38Cr 147.53Cr 137.21Cr 253.53Cr 16TCr 281.76Cr 1.77TCr 675.87Cr 7.44TCr 694.67Cr 680.35Cr 27TCr | -55Cr -47Cr -44Cr -41Cr -76Cr -4.74TCr -84Cr -527.62Cr -201.73Cr -2.22TCr -207.34Cr -203.07Cr -8.15TCr |
More financial data
* Estimated data
Employees
7,605
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 134.21 $ | -0.83% | 10,44,649 |
| 10/25/10 | 135.33 $ | +1.74% | 9,92,049 |
| 09/25/09 | 133.02 $ | -1.07% | 15,28,822 |
| 08/25/08 | 134.46 $ | +3.33% | 13,50,819 |
| 07/25/07 | 130.13 $ | -2.06% | 10,86,980 |
Delayed Quote Nasdaq, July 12, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
135.33USD
Average target price
171.89USD
Spread / Average Target
+27.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition